Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIN28A pseudogene 3 (LIN28AP3) is a DNA sequence similar to the protein-coding LIN28A gene but classified as a pseudogene, indicating that it does not encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events and tend to lack biological activity other than potential regulatory effects in exceptional cases. LIN28AP3 is not considered a therapeutic target, and there is no evidence that it plays any known role in biology, pathology, or clinical pharmacology. The functional LIN28A protein (not LIN28AP3) is a highly conserved RNA-binding protein involved in pluripotency, cell growth, and cancer, but LIN28AP3 does not share these features[1][2][3][4][5].\n\nKey caveat: If the intention was to reference the genuine LIN28A protein (gene symbol: LIN28A), which is well-studied and potentially targetable for therapy, then this is a misidentification—the pseudogene LIN28AP3 itself is not an actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIN28A pseudogene 3 (LIN28AP3).